Cargando…
Therapeutic and Transmission-Blocking Efficacy of Dihydroartemisinin/Piperaquine and Chloroquine against Plasmodium vivax Malaria, Cambodia
We assessed the efficacy of standard 3-day courses of chloroquine and dihydroartemisinin/piperaquine against Plasmodium vivax malaria. Compared with chloroquine, dihydroartemisinin/piperaquine was faster in clearing asexual P. vivax parasites and blocking human-to-mosquito transmission. This drug co...
Autores principales: | Popovici, Jean, Vantaux, Amelie, Primault, Lyse, Samreth, Reingsey, Piv, Eak Por, Bin, Sophalai, Kim, Saorin, Lek, Dysoley, Serre, David, Menard, Didier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056113/ https://www.ncbi.nlm.nih.gov/pubmed/29798745 http://dx.doi.org/10.3201/eid2408.170768 |
Ejemplares similares
-
Impact of the first-line treatment shift from dihydroartemisinin/piperaquine to artesunate/mefloquine on Plasmodium vivax drug susceptibility in Cambodia
por: Roesch, Camille, et al.
Publicado: (2020) -
Genomic Analyses Reveal the Common Occurrence and Complexity of Plasmodium vivax Relapses in Cambodia
por: Popovici, Jean, et al.
Publicado: (2018) -
Characterization of P. vivax blood stage transcriptomes from field isolates reveals similarities among infections and complex gene isoforms
por: Kim, Adam, et al.
Publicado: (2017) -
Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations
por: Duru, Valentine, et al.
Publicado: (2015) -
Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
por: Assefa, Ashenafi, et al.
Publicado: (2022)